Originally from Mumbai, Ketaki attended the University of Mumbai as an undergraduate, majoring in Biotechnology. She did her Masters and research in the UK at the University of Sheffield in the Laboratory of Eva E Qwarnstrom, which ignited in her the curiosity for cardiovascular research. She then completed her Ph.D. in Molecular medicine in Austria and Germany at Medical University of Graz and Charité Medical University in the laboratory of Frank Heinzel and Burket Pieske. She studied and found a novel interaction between FGF23 and Angiotensin II pathway, pathways both critical in maladaptation leading to Heart Failure (HF).

Ketaki is excited to be working in the laboratories of Mike Regnier and Charles Murry for her postdoctoral work to continue exploring her interest in finding therapeutic strategies to treat HF and cardiovascular diseases using cutting edge new technologies, and investigating the novel regenerative cell therapy approach of engineering stem cells-derived cardiomyocytes-overexpressing Ribonucleotide reductases (RNR) against chronic myocardial infarction.